Simple jQuery Dropdowns

Browsing by Author Frances Priddy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
21-Jul-2018Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch; Frank L. Tomaka; Frank Wegmann; Daniel J. Stieh; Galit Alter; Merlin L. Robb; Nelson L. Michael; Lauren Peter; Joseph P. Nkolola; Erica N. Borducchi; Abishek Chandrashekar; David Jetton; Kathryn E. Stephenson; Wenjun Li; Bette Korber; Georgia D. Tomaras; David C. Montefiori; Glenda Gray; Nicole Frahm; M. Juliana McElrath; Lindsey Baden; Jennifer Johnson; Julia Hutter; Edith Swann; Etienne Karita; Hannah Kibuuka; Juliet Mpendo; Nigel Garrett; Kathy Mngadi; Kundai Chinyenze; Frances Priddy; Erica Lazarus; Fatima Laher; Sorachai Nitayapan; Punnee Pitisuttithum; Stephan Bart; Thomas Campbell; Robert Feldman; Gregg Lucksinger; Caroline Borremans; Katleen Callewaert; Raphaele Roten; Jerald Sadoff; Lorenz Scheppler; Mo Weijtens; Karin Feddes-de Boer; Daniëlle van Manen; Jessica Vreugdenhil; Roland Zahn; Ludo Lavreys; Steven Nijs; Jeroen Tolboom; Jenny Hendriks; Zelda Euler; Maria G. Pau; Hanneke Schuitemaker; Janssen Vaccines & Prevention B.V.; Centre for the AIDS Programme of Research in South Africa; International AIDS Vaccine Initiative; Makerere University; Janssen; Massachusetts Institute of Technology; Miami Research Associates; National Institute of Allergy and Infectious Diseases; Brigham and Women's Hospital; University of Witwatersrand; HJF; Walter Reed Army Institute of Research; Mahidol University; University of Colorado at Denver; Duke University; Los Alamos National Laboratory; Royal Thai Army; Fred Hutchinson Cancer Research Center; Harvard Medical School; University of Massachusetts Medical School; Optimal Research LLC; Tekton Research; Janssen Infectious Diseases; Rwanda Zambia HIV Research Group
1-Feb-2007Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USAJim Ackland; Susan Allen; Daniel Barth-Jones; Deborah Birx; Elwyn Chomba; Gavin Churchyard; Ann Duerr; Shuigao Jin; Margaret Johnston; Patricia E. Fast; Alan Fix; Mary Foulkes; Dean Follmann; Raymond Hutubessy; Siobhan Malone; Ronald Gray; Abhay Indrayan; Jonathan Levin; Bonnie J. Mathieson; Timothy D. Mastro; John McNeil; Saladin Osmanov; Punnee Pitisuttithum; Barry Peters; Etienne Karita; Michael N. Robertson; R. Ramakrishnan; Helen Rees; Wasima Rida; Yuhua Ruan; Eric Sandström; Claudia Schmidt; Peter Smith; Steven Self; Georges Thiry; Judith Wasserheit; Frances Priddy; Ibou Thior; Mitchell Warren; David Cooper; Pontiano Kaleebu; Ruth Macklin; Godfrey Tangwa; Global BioSolutions; Rollins School of Public Health; Wayne State University School of Medicine; Centers for Disease Control and Prevention; Zambia-UAB HIV Research Project; Ernest Oppenheimer Hospital; Scientific Support Unit; Chinese Center for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; International AIDS Vaccine Initiative; Food and Drug Administration; Organisation Mondiale de la Sante; Bill and Melinda Gates Foundation; Johns Hopkins Bloomberg School of Public Health; University College of Medical Sciences; South African Medical Research Council; OAR HIV/AIDS Vaccine Coordinating Committee; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mahidol University; Guy's and St Thomas' NHS Foundation Trust; Projet San Francisco Rwanda; Merck & Co., Inc.; National Institute of Epidemiology; University of Witwatersrand; Statistics Collaborative; Karolinska University Hospital; London School of Hygiene & Tropical Medicine; Statistical Center for HIV/AIDS Research and Prevention; IAVI; HIV Vaccine Trials Network; Emory University; Botswana Harvard AIDS Institute Partnership; AIDS Vaccine Advocacy Coalition; Kirby Institute; Uganda Virus Research Institute; Albert Einstein College of Medicine of Yeshiva University; Universite de Yaounde I